teclistamab
genmab,Janssen
the european commission granted a conditional marketing authorization for teclistimab in myeloma. first in class bispecific antibody. good news. hope fda approval follows soon. #ims2022 
Editor-in-Chief, Blood Cancer Journal; Giants of Cancer Care Award; Myeloma; Cancer Research; Opinions are personal views; @CovidThreads; https://t.co/HOGYJSpsoG